Novartis loses EU court bid to revoke inhaler trademark

16-03-2023

Liz Hockley

Novartis loses EU court bid to revoke inhaler trademark

Dispute relates to AstraZeneca's ‘Breztri’ brand | Court says no likelihood of confusion with earlier marks | Full details of reasoning. 


Novartis, AstraZeneca, inhaler, trademark, EU Intellectual Property Office, Breztri, EUIPO Board of Appeal

LSIPR